Gregory David
New York University School of Medicine, USA
Biography
David G, PhD, is an Associate Professor of Biochemistry and Molecular Pharmacology at NYU School of Medicine. He received Graduation degree in Molecular Biology from the Pasteur Institute in Paris, studying the bases for acute promyelocytic leukemia. He then did his Post-doctoral work at the Dana Farber Cancer Institute, studying the interplay between chromatin modifiers and cancer using mouse models. His laboratory currently investigates the impact of epigenetic processes in early stages of prostate and pancreatic cancer progression. Recently, his work has focused on the contribution of chromatin modifiers on cell fate decisions, including cellular senescence, as modulators of tumorigenesis, and by inference the identification of epigenetic pathways that can serve as therapeutic targets to prevent cancer progression.
Abstract
Abstract : Targeting senescence associated inflammation to prevent pancreatic cancer progression